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Abstract
Background: Cluster headache (CH) is a neurovascular, primary headache disorder. There are,
however, several case reports about patients whose CH started shortly after a structural brain
disease or trauma. Motivated by a patient who developed CH 3 weeks after the removal of an eye
and by similar case reports, we tested the hypothesis that the removal of an eye is a risk factor for
CH.
Methods: A detailed headache questionnaire was filled out by 112 patients on average 8 years after
enucleation or evisceration of an eye.
Results: While 21 % of these patients experienced previously unknown headaches after the
removal of an eye, no patient fulfilled the diagnostic criteria for CH.
Conclusion: Our data does not suggest that the removal of an eye is a major risk factor for the
development of CH.
Background
Cluster headache (CH) is characterized by severe attacks
of unilateral pain and cranial autonomic dysfunction [1].
The pain is usually felt in and around the orbita or adja-
cent areas of the head (Fig. 1). CH attacks last 15–180
minutes and occur, during a cluster period, from once
every other day to several times a day. The symptoms of
autonomic dysfunction are always ipsilateral to the pain
and can involve the eye (conjunctival injection, lacrima-
tion, miosis, ptosis, eyelid edema), the nose (nasal con-
gestion, rhinorrhea), and the face (sweating) [1]. The
exact pathophysiology of CH is, more than 250 years after
the first description of episodic CH by Gerhard van Swi-
eten in 1745 [2], still unresolved. Several convergent lines
of evidence suggest that CH is a primary neurovascular
disorder (for review see [3]). The hypothalamus is sup-
posed to be involved in the pathogenesis of CH and might
even be pivotal for the timing of cluster periods and single
attacks [4].
Challenging the notion of an exclusively primary head-
ache disorder, several reports described the onset of CH
during or shortly after traumatic brain injury [5,6] or
structural brain disease (reviewed in [7,8]). In many of
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these reports, vascular disorders (e.g. arterio-venous mal-
formations [9,10], aneurysms [11], dissections [12], or fis-
tulas [13] of the cranial vasculature) were associated with
the onset of CH. In other patients, intracranial neoplasms
(e.g. meningeomas [14], adenomas [15]) or local inflam-
matory processes [16,17] were seen in connection with
the beginning of CH. All reports on putative secondary
CH face the difficult question whether there is a causal
relationship or a mere coincidence between CH and the
preceding brain injury or disease. The International Clas-
sification of Headache Disorders suggests to code a head-
ache with the characteristics of a primary headache (e.g.
CH) as a secondary headache if it occurs for the first time
and in close temporal relation to another disorder that is
a known cause of headache [1]. We follow the phenome-
nologic classification of the International Headache Soci-
ety (IHS) [18] and regard all headaches with the
symptomatology of CH and developing in a close tempo-
ral relationship to a brain injury or disease as secondary
headaches.
In addition to the aforementioned patients, we saw a 37-
year-old man who fulfilled the IHS criteria for a secondary
CH. He developed strictly right-sided episodic CH 3 weeks
after the removal of his right eye bulb [19]. The patient
not only fulfilled the diagnostic criteria for CH [1], but
also responded to standard acute and prophylactic CH
therapy. At least another 5 patients, all of them male,
could be identified in the literature who developed CH,
either episodic or chronic, after the removal of the eye
bulb [19]. Episodic CH originated in a 45-year-old man
one year after maxillectomy and exenteration due to a
squamous cell carcinoma [20]. In other patients, however,
CH developed up to 18 years after surgery [21]. Despite
the suggestive chronology in our patient with a latency
between surgery and first CH attack of only 3 weeks, it
remained unclear if the removal of the eye influenced the
development of CH or if both events were unrelated. To
test the hypothesis that removal of an eye is a risk factor
for CH we conducted a retrospective survey among indi-
viduals whose eye had to be resected.
Methods
To identify patients who underwent the removal of an eye,
the clinical records of all inpatients admitted to the
Department of Ophthalmology, Minister University Hos-
pital between 1986 and 1995 were reviewed. In total, 332
patients had enucleation or evisceration of one eye in the
specified time frame. All patients received a detailed ques-
tionnaire via mail asking about the occurrence and clini-
cal presentation of headaches before and after the removal
of the bulb (33 questions in total). The questionnaire was
developed by the authors and included, amongst others,
questions about the location, the quality, the duration of
individual headache attacks, the occurrence of cluster
periods, and the typical autonomic features of CH. The
questionnaire included all diagnostic criteria for CH as
described in the International Classification of Headache
Disorders [1], but it was not formally validated. The
patients were asked to return the completed questionnaire
in a pre-paid envelope by mail. Medical records were con-
sulted for personal data, the ophthalmologic diagnosis
leading to the removal of the eye, and the operative tech-
nique used. A different aspect of this study regarding the
prevalence and phenomenology of phantom experiences
after removal of the eye was published previously [22].
The 37-year-old man who developed CH 3 weeks after
removal of the ipsilateral eye, reported by us [19], was not
included in the study population presented here because
surgery was performed in an external hospital. A post-hoc
analysis of statistical power was performed to assess the
minimum effect size observable by the available sample
size using the statistical package R for Mac OS X [23]. This
Pain in cluster headache Figure 1
Pain in cluster headache. The location of intense pain, 
usually orbital or supraorbital, in a CH attack, overlayed onto 
the portrait of Franz Kafka (1924). Kafka suffered from 
extremely severe headache attacks, possibly CH [39].BMC Neurology 2005, 5:6 http://www.biomedcentral.com/1471-2377/5/6
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analysis was based on the prevalence of CH found in two
recent epidemiological studies [24,25]. The required
statistical power was set to 0.8 and the significance level to
0.05.
Results
One hundred twelve patients (78 men and 34 women)
completed our questionnaire and were included in the
data analysis (response rate, 33.7 %). The average age at
the time of eye removal was 48 ± 21 years, and the average
latency between eye removal and completing the ques-
tionnaire was 8 ± 3 years (range, 3–19 years). The major
reasons for removal of the eye bulb were eye trauma (n =
40, 36 %), and malignant (n = 22, 20 %) or non-malig-
nant eye diseases (n = 50, 44 %). Enucleation (removal of
the globe with sparing of the extraocular muscles [26] was
performed in 104 patients (93 %), and evisceration
(removal of the contents of the globe with the sclera and
the extraocular muscles left intact) was done in 8 patients
(7 %). After the removal of the bulb, 24 patients (21 %)
experienced previously unknown headaches. Although 13
of those patients reported strictly unilateral headaches
(usually ipsilateral to the removed eye bulb), the charac-
teristic autonomic symptoms of cluster headache and the
typical temporal pattern of headache attacks were absent
in all of those patients. None of the patients thus fulfilled
the diagnostic criteria for CH [1]. The power analysis
revealed that a CH prevalence of 5.5 or more in our group
of 112 patients would have resulted in a significant
increase of CH prevalence (based on a population-wide
CH prevalence of 56/100,000 [25]). Based on a CH prev-
alence of 326/100,000 [24], a prevalence of 6.2 or more
would have been significant.
Discussion
This retrospective study on 112 patients could not identify
individuals who developed CH 3 – 19 years after removal
of an eye bulb. During enucleation, the predominant
technique used in our patients, the globe has to be sepa-
rated from all orbital tissue, including the external eye
muscles and the optic nerve (Fig. 2) [26]. The eye is inner-
vated by the optic nerve, the nasociliary nerve and the
sympathetic and parasympathetic fibers. This led us to the
hypothesis that lesions of the autonomic network might
induce secondary CH in patients after enucleation [19].
Similar mechanisms have been discussed in a patient with
secondary CH due to an intracranial inflammatory pseu-
dotumor in the posterior fossa [27]. Our result, however,
does not provide evidence for the notion that a first CH
attack after the removal of the bulb, as observed previ-
ously [19,20], is triggered or at least facilitated by the irri-
tation of trigemino-autonomic nervous structures during
surgery and wound healing. The techniques of eviscera-
tion and enucleation spare parts of the orbita (especially
the external eye muscles) and usually do not affect the cra-
nial nerves III, IV, and VI. During exenteration, on the
other hand, the entire orbital content has to be removed.
Patients with exenteration were not included in this study
because this technique is used less frequently and mainly
in cancer patients (which makes longer follow-up periods
difficult). Patients with exenteration might be especially
prone to develop CH because this procedure results in
extensive damage of nervous tissue. As CH pain is often
located in or around the orbita and the autonomic symp-
toms of CH usually involve the eye, it has been speculated
if CH can occur without an ipsilateral eye. Patients devel-
oping ipsilateral CH after the removal of an eye [19] irre-
spective of the temporal relationship between these two
events, clearly demonstrate that the eye and the surround-
ing tissues are not essential for the pathogenesis of CH.
CH usually develops between 20 and 45 years [28], with
a mean age of onset of about 29 years [29,30]. CH, how-
ever, can start much later in life. Patients with a first CH
Orbital anatomy Figure 2
Orbital anatomy. High-resolution axial T1-weighted native 
MRI of a volunteer without structural abnormalities at 3.0 
Tesla. Structures removed during enucleation (globe, part of 
the optic nerve, insertions of the external eye muscles) are 
highlighted by the red ellipse.BMC Neurology 2005, 5:6 http://www.biomedcentral.com/1471-2377/5/6
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attack at the age of 83 years and 75 years have been
described [31]. As the mean age in our patients (48 years)
is higher than the mean age of onset of CH, one might
speculate that, in many of our patients, the removal of the
eye was done when they were less susceptible for the
development of CH. We do not suppose that the age dif-
ference between our sample of patients after eye removal
and patients with first CH attack significantly influenced
the result of this study. The reports on patients who devel-
oped CH in their 70ies and 80ies demonstrate that higher
age does not prevent the development of CH. Moreover,
many patients with secondary CH were older than the
average age of onset of primary CH. The age of onset of the
5 patients with a first CH attack after removal of the eye
was 36 years [19].
The presented study, however, has its limitations. The ret-
rospective, questionnaire-based design might underesti-
mate the prevalence of CH. Descriptions of the main
symptoms of CH, however, either in questionnaires or let-
ters, have proven to be useful in several epidemiological
studies on CH [25,32-36] and take advantage of the dis-
tinct diagnostic criteria and the impressive nature of CH.
The use of short self-adminstered questionnaires for
screening larger populations has also been validated in
migraine [37,38]. Our study was designed to screen our
population via a questionnaire and then to verify each
probable diagnosis of CH with a detailed interview and a
comprehensive neurological examination (no patient,
however, reported the main features of CH, short attacks
of unilateral, severe headaches in bouts). Individuals with
infrequent and mild bouts, however, might not recall past
CH attacks while responding to a questionnaire. In addi-
tion, the relatively low response rate (34 %) might have
influenced the present results. On the one hand, patients
with CH might be hidden in the group of individuals not
responding to our questionnaire. On the other hand,
patients with CH are probably more willing to respond to
a survey targeted at their symptoms than patients with
other forms of headache or without headaches at all. In
general, a prospective study which includes patients
before the removal of an eye, follows them over years and
then compares the outcome to a control group (i.e., a
cohort study) would be more effective for the study of a
disease's risk factors. In addition, CH is rare with a preva-
lence of less than 1 %. Investigating possible risk factors
for rare disorders requires large sample or effect sizes. Our
sample size is large enough to yield statistical significance
for a CH prevalence of 5.5 % in our group (or 6.2 %,
depending on the assumed population-wide CH preva-
lence), but might be too small to detect a slight increase of
CH among patients after removal of an eye.
Conclusion
Our data does not suggest that the removal of the globe is
a major risk factor for the development of CH. We cannot
exclude the possibility that enucleation is associated with
a small increase in CH prevalence.
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